VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CPHI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CPHIChina Pharma Holdings, Inc.
$0.73$2M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCPHIQuarterly Financials

China Pharma Holdings, Inc. (CPHI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

China Pharma Holdings, Inc. (CPHI) quarterly income statement — complete revenue, gross profit & net income history

CPHI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue983.54K1.23M756.22K1.03M1.14M1.13M1.1M924.94K1.37M2.15M1.8M1.1M1.96M2.92M1.97M1.61M1.6M2.89M1.98M2.42M
Revenue Growth %-13.44%8.11%-31.26%10.9%-17.05%-47.25%-39%-15.75%-30.12%-26.41%-8.26%-31.94%22.21%1.09%-0.64%-33.22%-31.99%-1.42%-17.58%-35.94%
Cost of Goods Sold1.52M1.08M815.87K1.11M1.27M1.19M1.62M2.05M1.66M2.23M2.04M1.24M1.78M2.88M2.1M1.84M1.77M2.59M2.28M2.34M
COGS % of Revenue154.88%87.7%107.89%108.48%111.97%104.91%147.23%221.12%121.17%103.68%112.93%113.36%90.92%98.54%107.01%114.22%110.56%89.55%114.98%97.06%
Gross Profit-539.79K150.78K-59.65K-87.01K-136.06K-55.67K-519.65K-1.12M-290.02K-79.16K-233.19K-146.66K177.92K42.68K-137.76K-229.38K-169.46K301.94K-296.4K71K
Gross Margin %-54.88%12.3%-7.89%-8.48%-11.97%-4.91%-47.23%-121.12%-21.17%-3.68%-12.93%-13.36%9.08%1.46%-7.01%-14.22%-10.56%10.45%-14.98%2.94%
Gross Profit Growth %-296.73%370.85%88.52%92.23%53.09%29.68%-122.84%-663.88%-263%-285.46%-69.28%36.06%204.99%-85.86%53.52%-423.07%-162.14%-46.22%-728.01%-93.83%
Operating Expenses577.47K1.35M568.49K565.11K622.56K1.14M565.61K271.21K626.03K1.11M480.35K309.65K575.4K1.21M550.9K550.21K742.26K950.63K466.01K823.95K
OpEx % of Revenue58.71%110.24%75.18%55.09%54.79%100.56%51.41%29.32%45.7%51.42%26.63%28.2%29.35%41.48%28.02%34.11%46.28%32.9%23.55%34.11%
Selling, General & Admin493.71K1.19M502.87K542.13K594.29K1.03M479.65K203.32K596.64K949.34K452.79K281.85K562.43K1.19M535.99K539.51K693.73K1.15M436.26K775.24K
SG&A % of Revenue50.2%96.9%66.5%52.85%52.3%91.18%43.6%21.98%43.56%44.16%25.11%25.67%28.69%40.87%27.26%33.44%43.25%39.7%22.05%32.09%
Research & Development83.76K190.04K40.32K20.95K29.59K54787.61K164.33K31.45K147.55K45.77K23.75K23.01K28K88.75K15.06K54.05K54.05K21.37K53.46K
R&D % of Revenue8.52%15.5%5.33%2.04%2.6%0.05%7.96%17.77%2.3%6.86%2.54%2.16%1.17%0.96%4.51%0.93%3.37%1.87%1.08%2.21%
Other Operating Expenses0-26.46K25.3K2.03K-1.32K105.87K-1.66K-96.45K-2.07K8.44K-18.21K4.05K-10.04K-10.14K-73.84K-4.36K-5.52K-250.62K8.37K-4.74K
Operating Income-1.12M-1.2M-628.14K-652.12K-758.62K-1.2M-1.09M-1.39M-916.05K-1.18M-713.54K-456.31K-397.48K-1.17M-688.65K-779.59K-911.72K-648.69K-762.4K-752.95K
Operating Margin %-113.6%-97.9%-83.06%-63.57%-66.76%-105.47%-98.65%-150.44%-66.87%-55.1%-39.57%-41.56%-20.28%-40.02%-35.03%-48.33%-56.84%-22.45%-38.53%-31.17%
Operating Income Growth %-47.28%-0.35%42.12%53.14%17.19%-0.97%-52.09%-204.95%-130.47%-1.32%-3.61%41.47%56.4%-80.21%9.67%-3.54%-30.91%41.11%19.96%-1104.13%
EBITDA-136.69K-702.77K-272.11K-331.26K-429.31K-747.96K-388.31K-649.88K-182.25K-488.66K-30.45K238.53K282.4K-529.59K-24.32K-96.38K-198.16K62.03K214.05K-52.49K
EBITDA Margin %-13.9%-57.32%-35.98%-32.29%-37.78%-65.96%-35.3%-70.26%-13.3%-22.73%-1.69%21.73%14.41%-18.13%-1.24%-5.97%-12.35%2.15%10.82%-2.17%
EBITDA Growth %68.16%6.04%29.92%49.03%-135.55%-53.07%-1175.33%-372.45%-164.54%7.73%-25.21%347.5%242.51%-953.81%-111.36%-83.62%-5428.34%115.49%176.67%-107.25%
D&A (Non-Cash Add-back)980.57K497.43K356.03K320.86K329.31K448.07K696.94K741.64K733.8K695.84K683.09K694.84K679.88K639.42K664.34K683.21K713.56K710.72K976.46K700.46K
EBIT-1.12M-1.2M-627.44K-501.01K-757.54K-1.19M-1.08M-1.39M-913.74K-1.18M-711.36K-455.37K-396.53K-1.17M-686.8K-778.35K-905.06K-647.28K-761.77K-752.37K
Net Interest Income-25.88K-22.39K-23.75K-26.94K-26.95K-28.4K-32.65K-46.61K-39.84K-47.72K-64.06K-136.72K-78.5K-95.17K-102.12K-108.8K-117.77K-332.03K-64.27K-71.81K
Interest Income1472132944221.07K1.33K1.46K1.53K2.31K2.53K2.18K9429481K1.86K1.24K6.66K1.41K638579
Interest Expense26.03K22.6K24.05K27.36K28.03K29.73K34.11K48.14K42.16K50.25K66.24K137.66K79.44K96.17K103.98K110.04K124.43K333.44K64.9K72.39K
Other Income/Expense-25.88K-21.94K-23.34K123.75K-26.95K-28.4K-32.65K-46.61K-39.84K-47.72K-64.06K-136.72K-78.5K-95.17K-102.12K-108.8K-117.77K-332.03K-64.27K-71.81K
Pretax Income-1.14M-1.22M-651.48K-528.37K-785.57K-1.22M-1.12M-1.44M-955.89K-1.23M-777.6K-593.03K-475.98K-1.26M-790.77K-888.39K-1.03M-980.72K-826.67K-824.76K
Pretax Margin %-116.23%-99.69%-86.15%-51.51%-69.14%-107.98%-101.61%-155.48%-69.78%-57.32%-43.12%-54.02%-24.28%-43.28%-40.22%-55.07%-64.18%-33.94%-41.78%-34.14%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.14M-1.22M-651.48K-528.37K-785.57K-1.22M-1.12M-1.44M-955.89K-1.23M-777.6K-593.03K-475.98K-1.26M-790.77K-888.39K-1.03M-980.72K-826.67K-824.76K
Net Margin %-116.23%-99.69%-86.15%-51.51%-69.14%-107.98%-101.61%-155.48%-69.78%-57.32%-43.12%-54.02%-24.28%-43.28%-40.22%-55.07%-64.18%-33.94%-41.78%-34.14%
Net Income Growth %-45.52%0.19%41.72%63.26%17.82%0.63%-43.76%-142.51%-100.83%2.53%1.67%33.25%53.77%-28.9%4.34%-7.72%-34.17%18.88%18.14%-6418.56%
Net Income (Continuing)-1.14M-1.22M-651.48K-528.37K-785.57K-1.22M-1.12M-1.44M-955.89K-1.23M-777.6K-593.03K-475.98K-1.26M-790.77K-888.39K-1.03M-980.72K-826.67K-824.76K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.27-0.23-0.17-0.16-0.18-0.26-0.23-0.30-0.20-0.26-0.16-0.12-0.10-0.21-0.79-0.50-0.57-0.64-0.18-0.18
EPS Growth %-50%11.54%26.09%46.67%10%0%-43.75%-150%-100%-23.81%79.75%76%82.46%67.19%-338.89%-177.78%-235.29%-128.57%21.74%-
EPS (Basic)-0.27-0.23-0.17-0.16-0.18-0.26-0.23-0.30-0.20-0.26-0.16-0.12-0.10-0.21-0.79-0.51-0.57-0.64-0.18-0.18
Diluted Shares Outstanding4.29M4.29M3.87M3.26M4.26M4.76M4.76M4.76M4.76M4.76M4.76M4.76M4.76M6.44M4.61M4.94M4.74M4.78M4.61M4.61M
Basic Shares Outstanding4.29M4.29M3.87M3.26M4.26M4.76M4.76M4.76M4.76M4.76M4.76M4.76M4.76M6.44M4.61M4.85M4.74M4.78M4.61M4.61M
Dividend Payout Ratio--------------------